Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary cutaneous lymphomas.

R Willemze1

  • 1Department of Dermatology, Leiden University Medical Center, The Netherlands. willemze.dermatology@lumc.nl

Current Opinion in Oncology
|September 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clear cell acanthoma on the dorsum of the hand.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.

The British journal of dermatology·2014
Same author

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).

Annals of hematology·2014
Same author

Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma.

The British journal of dermatology·2014
Same author

Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides.

The British journal of dermatology·2013
Same author

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.

Bone marrow transplantation·2013
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Primary cutaneous lymphomas require distinct therapeutic strategies. This review compares the European Organization for Research and Treatment of Cancer (EORTC) classification with the WHO classification, focusing on T-cell and B-cell lymphomas.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Primary cutaneous lymphomas (PCLs) exhibit unique clinical behaviors and prognoses.
  • PCLs necessitate different therapeutic approaches compared to primary nodal lymphomas.
  • Accurate classification is crucial for effective PCL management.

Purpose of the Study:

  • To discuss the relationship between the European Organization for Research and Treatment of Cancer (EORTC) classification and the World Health Organization (WHO) classification for PCLs.
  • To present recent advancements in understanding key cutaneous T-cell lymphomas (CTCLs) and cutaneous B-cell lymphomas (CBCLs).
  • To highlight the EORTC classification as a guide for optimal PCL management.

Main Methods:

  • Comparative analysis of the EORTC and WHO classification systems for PCLs.

Related Experiment Videos

  • Review of recent literature and developments concerning major CTCL and CBCL subtypes.
  • Synthesis of information to guide clinical management based on established classifications.

    • Main Results:

    • The EORTC classification provides a framework for managing a defined spectrum of PCLs.
    • The WHO classification offers an updated perspective on PCL categorization.
    • Understanding the interplay between these classifications aids in refining treatment strategies.

    Conclusions:

    • The EORTC classification remains a valuable tool for guiding the management of primary cutaneous lymphomas.
    • Alignment with the WHO classification enhances diagnostic accuracy and therapeutic planning.
    • Continued research into CTCLs and CBCLs is essential for improving patient outcomes.